← Back to Clinical Trials
Recruiting NCT05830903

NCT05830903 Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05830903
Status Recruiting
Phase —
Sponsor National Taiwan University Hospital
Condition Schizophrenia
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2020-01-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
VR-assisted occupational training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2020-01-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Establish a novel vocational training program and test its validity in a pilot study.

Eligibility Criteria

Inclusion Criteria: * Having a diagnosis of schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders -5th version * Aged between 20 and 55 years. * Motivated to have a job. * Having a full-scale IQ \> 70 on the Wechsler Adult Intelligence Scale-version IV. * Having a PANSS positive scale \< 70, indicating a stable condition during the illness course. Exclusion Criteria: * Comorbid with other major psychiatric disorders (i.e., bipolar disorders) or neurological diseases. * Substance abuse within one year. * Visual impairment and/or hearing impairment that would preclude participation in the VR-based training program.

Contact & Investigator

Central Contact

Yi Ling Chien

✉ ylchien@hotmail.com

📞 886-2-2312-3456

Principal Investigator

Yi Ling Chien

PRINCIPAL INVESTIGATOR

National Taiwan University Hospital

Frequently Asked Questions

Who can join the NCT05830903 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Schizophrenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05830903 currently recruiting?

Yes, NCT05830903 is actively recruiting participants. Contact the research team at ylchien@hotmail.com for enrollment information.

Where is the NCT05830903 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT05830903 clinical trial?

NCT05830903 is sponsored by National Taiwan University Hospital. The principal investigator is Yi Ling Chien at National Taiwan University Hospital. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology